Protara Therapeutics, Inc.
TARA
$3.97
$0.030.76%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 142.49M | 135.79M | 155.55M | 132.67M | 122.22M |
| Total Receivables | 1.28M | 1.52M | 1.26M | 1.00M | 890.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 660.00K | 637.00K | 702.00K | 482.00K | 628.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.72M | 2.06M | 1.99M | 1.49M | 1.36M |
| Total Current Assets | 146.15M | 140.00M | 159.50M | 135.64M | 125.09M |
|
|
|||||
| Total Current Assets | 146.15M | 140.00M | 159.50M | 135.64M | 125.09M |
| Net Property, Plant & Equipment | 3.92M | 3.56M | 3.93M | 4.28M | 4.64M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 6.67M | 6.73M | 3.70M | 3.76M | 3.81M |
| Total Assets | 176.09M | 191.92M | 209.47M | 144.64M | 156.93M |
|
|
|||||
| Total Accounts Payable | 4.66M | 4.03M | 3.47M | 4.50M | 5.30M |
| Total Accrued Expenses | 7.37M | 3.63M | 6.23M | 4.19M | 3.26M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.29M | 1.26M | 1.24M | 1.22M | 1.20M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 13.32M | 8.92M | 10.94M | 9.91M | 9.76M |
|
|
|||||
| Total Current Liabilities | 13.32M | 8.92M | 10.94M | 9.91M | 9.76M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.46M | 1.79M | 2.12M | 2.44M | 2.75M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 14.78M | 10.72M | 13.06M | 12.35M | 12.51M |
|
|
|||||
| Common Stock & APIC | 503.54M | 501.77M | 498.74M | 417.26M | 416.20M |
| Retained Earnings | -341.87M | -320.20M | -302.42M | -285.11M | -271.85M |
| Treasury Stock & Other | -363.00K | -364.00K | 90.00K | 143.00K | 77.00K |
| Total Common Equity | 161.31M | 181.21M | 196.41M | 132.29M | 144.42M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 161.31M | 181.21M | 196.41M | 132.29M | 144.42M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 161.31M | 181.21M | 196.41M | 132.29M | 144.42M |
|
|
|||||